MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma

Published:2024-02-07 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Xu Hongyu¹,Du Zedong²,Li Zhihui³,Liu Xianguo¹,Li Xueting¹,Zhang Xuan⁴,Ma Jiayu¹

Affiliation:

1. Department of Oncology, 363 Hospital, Chengdu, Sichuan, P.R. China

2. Department of Oncology, Chengdu Second People’s Hospital, Chengdu, Sichuan, P.R. China

3. Department of Oncology, The General Hospital of Western Theater Command of PLA, Chengdu, Sichuan, P.R. China

4. Science and Education Department, 363 Hospital, Chengdu, Sichuan, P.R. China

Funder

Chengdu Health Commission Medical Foundation

General Medical research Fund project

Hospital-level incubation project of 363 Hospital

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2313671

Reference48 articles.

2. Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years

3. Primary lung adenocarcinoma: characteristics by smoking habit and sex

4. Non-small cell lung cancer: current treatment and future advances

5. Mechanisms of Taxol resistance related to microtubules

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma;Discover Oncology;2024-08-31

2. Emerging paradigms and recent progress in targeting ErbB in cancers;Trends in Pharmacological Sciences;2024-06

3. The Role of MUC1 in Renal Cell Carcinoma;Biomolecules;2024-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3